Hippo Tumor Supressor Pathway: Novel Implications for the Treatment of Hepatocellular Carcinoma

Philippa Newell, Augusto Villanueva, Judit Peix, Isabel Fiel, Swan N. Thung, Steven Yea, Sasan Roayaie, Myron Schwartz, Scott L. Friedman, Josep M. Llovet

Journal of the American College of Surgeons

Article2005

Updated treatment approach to hepatocellular carcinoma

Josep M. Llovet

Journal of Gastroenterology

Hippo Tumor Supressor Pathway: Novel Implications for the Treatment of Hepatocellular Carcinoma

Abstract

Discussion(0)

Related publications

1092 DISCOVERY OF NOVEL KINASE INHIBITORS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA

Treatment of hepatocellular carcinoma

Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma

Activation of Ras/MAPK and mTOR pathways in hepatocellular carcinoma: Tumor growth inhibition with Ras/mTOR pathway abrogation by a novel combination of Sorafenib and rapamycin

Updated treatment approach to hepatocellular carcinoma